Improved carrier testing for multiple endocrine neoplasia, type 1, using new microsatellite-type DNA markersKYTÖLÄ, S; LEISTI, J; WINQVIST, R et al.Human genetics. 1995, Vol 96, Num 4, pp 449-453, issn 0340-6717Article

myc oncogenes: activation and amplificationALITALO, K; KOSKINEN, P; MAKELA, T. P et al.Biochimica et biophysica acta. 1987, Vol 907, Num 1, pp 1-32, issn 0006-3002Article

Aberrant expression of an amplified c-myb oncogene in two cell lines from a colon carcinomaALITALO, K; WINQVIST, R; LIN, C. C et al.Proceedings of the National Academy of Sciences of the United States of America. Biological sciences. 1984, Vol 81, Num 14, pp 4534-4538, issn 0273-1134Article

Breast-Cancer Risk in Families with Mutations in PALB2ANTONIOU, A. C; CASADEI, S; TOMIAK, E et al.The New England journal of medicine. 2014, Vol 371, Num 6, pp 497-506, issn 0028-4793, 10 p.Article

Familial breast cancer screening reveals an alteration in the RAP80 UIM domain that impairs DNA damage response functionNIKKILÄ, J; COLEMAN, K. A; MORRISSEY, D et al.Oncogene (Basingstoke). 2009, Vol 28, Num 16, pp 1843-1852, issn 0950-9232, 10 p.Article

Mutation analysis of aryl hydrocarbon receptor interacting protein (AIP) gene in colorectal, breast, and prostate cancersGEORGITSI, M; KARHU, A; WINQVIST, R et al.British journal of cancer. 2007, Vol 96, Num 2, pp 352-356, issn 0007-0920, 5 p.Article

ATM mutations in finnish breast cancer patientsALLINEN, M; LAUNONEN, V; LAAKE, K et al.Journal of medical genetics. 2002, Vol 39, Num 3, pp 192-196, issn 0022-2593Article

Mutation analysis of BRCA1 and BRCA2 in Turkish cancer families : a novel mutation BRCA2 3414de14 found in male breast cancerBALCI, A; HUUSKO, P; PÄÄKKÖNEN, K et al.European journal of cancer (1990). 1999, Vol 35, Num 5, pp 707-710, issn 0959-8049Article

Population variation at the polymorphic ApaLI restriction enzyme site in intron 5 of the WT1 geneBESNARD-GUERIN, C; WINQVIST, R; NEWSHAM, I et al.Clinical genetics. 1996, Vol 50, Num 6, pp 555-557, issn 0009-9163Article

Chromosomal localization to 3q21→qter and two TaqI RFLPs of human prostate-specific acid phosphatase gene (ACPP)WINQVIST, R; VIRKKUNEN, P; GRZESCHIK, K.-H et al.Cytogenetics and cell genetics. 1989, Vol 52, Num 1-2, pp 68-71, issn 0301-0171Article

Mouse and human ornithine decarboxylase genes: methylation polymorphism and amplificationALHONEN-HONGISTO, L; LEINONEN, P; SINERVIRTA, R et al.Biochemical journal (London. 1906). 1987, Vol 242, Num 1, pp 205-210, issn 0006-2936Article

No evidence of involvement of germline BACH1 mutations in Finnish breast and ovarian cancer familiesKARPPINEN, S.-M; VUOSKU, J; HEIKKINEN, K et al.European journal of cancer (1990). 2003, Vol 39, Num 3, pp 366-371, issn 0959-8049, 6 p.Article

Germ-line TP53 mutations in Finnish cancer families exhibiting features of the Li-Fraumeni syndrome and negative for BRCA1 and BRCA2HUUSKO, P; CASTREN, K; LAUNONEN, V et al.Cancer genetics and cytogenetics. 1999, Vol 112, Num 1, pp 9-14, issn 0165-4608Conference Paper

Unstable DNA may be responsible for the incomplete penetrance of the myotonic dystrophy phenotypeSHELBOURNE, P; WINQVIST, R; KUNERT, E et al.Human molecular genetics (Print). 1992, Vol 1, Num 7, pp 467-473, issn 0964-6906Article

Intrachromosomal rearrangements fusing L-myc and rlf in small-cell lung cancerMAKELA, T. P; KERE, J; WINQVIST, R et al.Molecular and cellular biology (Print). 1991, Vol 11, Num 8, pp 4015-4021, issn 0270-7306Article

The gene for 17beta-hydroxysteroid dehydrogenase maps to human chromosome 17, bands q12-q21, and shows an RFLP with ScaIWINQVIST, R; PELTOKETO, H; ISOMAA, V et al.Human genetics. 1990, Vol 85, Num 5, pp 473-476, issn 0340-6717, 4 p.Article

Chromosome 7 long arm deletion in myeloid disorders: a narrow breakpoint region in 7q22 defined bu molecular mappingKERE, J; RUUTU, T; DAVIES, K. A et al.Blood. 1989, Vol 73, Num 1, pp 230-234, issn 0006-4971Article

A new RFLP with StuI and probe cX55.7 (DXS105) and its usefulness in carrier analysis of fragile X syndromeREKILA, A.-M; VAISANEN, M.-L; KAHKONEN, M et al.Human genetics. 1988, Vol 80, Num 2, issn 0340-6717, 193Article

Plasminogen activator inhibitor type 1 gene is located at region q21.3-q22 of chromosome 7 and genetically linked with cystic fibrosisKLINGER, K. W; WINQVIST, R; GRZESCHIK, K.-H et al.Proceedings of the National Academy of Sciences of the United States of America. 1987, Vol 84, Num 23, pp 8548-8552, issn 0027-8424Article

Germline TP53 alterations in Finnish breast cancer families are rare and occur at conserved mutation-prone sitesRAPAKKO, K; ALLINEN, M; WINQVIST, R et al.British journal of cancer. 2001, Vol 84, Num 1, pp 116-119, issn 0007-0920Article

Mutation analysis of the CHK2 gene in families with hereditary breast cancerALLINEN, M; HUUSKO, P; MÄNTYNIEMI, S et al.British journal of cancer. 2001, Vol 85, Num 2, pp 209-212, issn 0007-0920Article

European multicenter study on LOH of APOC3 at 11q23 in 766 breast cancer patients : relation to clinical variablesLAUNONEN, V; LAAKE, K; SEITZ, S et al.British journal of cancer. 1999, Vol 80, Num 5-6, pp 879-882, issn 0007-0920Article

Loss of heterozygosity for chromosome 11 in primary human breast tumors is associated with poor survival after metastasisWINQVIST, R; HAMPTON, G. M; CAVENEE, W. K et al.Cancer research (Baltimore). 1995, Vol 55, Num 12, pp 2660-2664, issn 0008-5472Article

Application of fine-needle aspiration to the demonstration of ERBB2 and MYC expression by in situ hybridization in breast carcinomaSOINI, Y; MANNERMAA, A; WINQVIST, R et al.The Journal of histochemistry and cytochemistry. 1994, Vol 42, Num 6, pp 795-803, issn 0022-1554Article

A point mutation in the putative TATA box, detected in nondiseased individuals and patients with hereditary breast cancer, decreases promoter activity of the 17β-hydroxysteroid dehydrogenase type 1 gene 2 (EDH17B2) in vitroPELTOKETO, H; YUNGHSANG PIAO; MANNERMAA, A et al.Genomics (San Diego, Calif.). 1994, Vol 23, Num 1, pp 250-252, issn 0888-7543Article